XML 23 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended 22 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES :      
Net loss $ (1,030,915) $ (409,540) $ (2,129,052)
Adjustments to reconcile net loss to net cash (used in) operating activities:      
Depreciation 1,053 251 1,730
Expenses paid by related party on behalf of Company 20,387 0 20,387
Loan receivable write off 21,405 0 21,405
Loss on acquisition 0 0 292,226
Deposit write off 0 0 162,371
Changes in operating assets and liabilities:      
Prepaid expenses 549 1,913 (250)
Inventory deposit (81,751) (165,013) (244,122)
Inventory (17,233) 0 (17,233)
Related party payables 367,636 133,170 469,134
Accounts payable 92,010 33,515 163,475
Accrued interest-related party 53,926 800 53,926
Accrued liabilities and interest 29,231 23,142 57,684
Net cash used in operating activities (543,702) (381,762) (1,148,319)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Factoring loan (19,477) 0 (19,477)
Addition of capital assets (600) (3,194) (4,713)
Net cash provided by investing activities (20,077) (3,194) (24,190)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Shareholder loan received 0 330,563 42,606
Net proceeds from loans payable 0 0 282,840
Net proceeds from related parties 359,867 (12,170) 454,891
Proceeds from note payable 200,000 0 200,000
Repayment of debt (84,265) 0 (134,265)
Proceeds from sale of debentures 275,000 0 275,000
Proceeds from the sale of common stock 9,677 72,043 262,455
Net cash provided by financing activities 760,279 390,436 1,383,527
Effect of foreign exchange loss 2,127 (6,130) (947)
Net increase (decrease) in cash and cash equivalents 198,627 (650) 210,071
Cash and cash equivalents at beginning of period 11,444 881 0
Cash and cash equivalents at end of period 210,071 231 210,071
Supplemental Schedule of Cash Flow Information:      
Cash paid for interest 0 0 0
Cash paid for taxes 0 0 0
Non Cash financial activities:      
Common stock issued in settlement of loans 98,700 0 138,700
Common stock issued for reverse acquisition 0 0 5,895
Common stock issued for payment of consulting fees payable 50,000 0 50,000
Debentures issued for settled of consulting fees payable 50,000 0 50,000
Debentures issued for settlement of loans $ 100,000 $ 0 $ 100,000